Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Thymoma × Octreotide × Clear all

Phase

Status

Sponsor Class

NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vipoma 2 Somatostatinoma 2 Rectal Neoplasms 2 Insulinoma 2 Glucagonoma 2 Gastrinoma 2 Colorectal Neoplasms 2 Carcinoma, Islet Cell 2 Thymoma 1 Neuroendocrine Tumors 1 Neoplasms 1 Meningioma 1 Drug-Related Side Effects and Adverse Reactions 1 Diarrhea 1 Colonic Neoplasms 1 Breast Neoplasms 1 Anus Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Taxes 2 Paclitaxel 2 Carboplatin 2 Ramucirumab 1 Proton Therapy 1 Prednisone 1 Octreotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003283 2023-06-15

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Eastern Cooperative Oncology Group

Phase 2 Completed

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡